Your browser doesn't support javascript.
loading
Resistance mechanisms to immune checkpoints blockade by monoclonal antibody drugs in cancer immunotherapy: Focus on myeloma.
Isazadeh, Alireza; Hajazimian, Saba; Garshasbi, Hamid; Shadman, Behrouz; Baghbanzadeh, Amir; Chavoshi, Reza; Taefehshokr, Sina; Farhoudi Sefidan Jadid, Mahdieh; Hajiasgharzadeh, Khalil; Baradaran, Behzad.
Afiliação
  • Isazadeh A; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Hajazimian S; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Garshasbi H; Department of Genetic, Tabriz Branch, Islamic Azad University, Tabriz, Iran.
  • Shadman B; Ege University Medical School, Department of Medical Biology, Izmir, Turkey.
  • Baghbanzadeh A; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Chavoshi R; Department of Genetic, Tabriz Branch, Islamic Azad University, Tabriz, Iran.
  • Taefehshokr S; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Farhoudi Sefidan Jadid M; Department of Genetic, Tabriz Branch, Islamic Azad University, Tabriz, Iran.
  • Hajiasgharzadeh K; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Baradaran B; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
J Cell Physiol ; 236(2): 791-805, 2021 02.
Article em En | MEDLINE | ID: mdl-32592235

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Anticorpos Monoclonais / Mieloma Múltiplo Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Anticorpos Monoclonais / Mieloma Múltiplo Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Irã